VAERS Datenanalyse und Statistik
VAERS DatenanalyseSuche nach Chargen, Symptomen, Reports und Statistiken
Zurueck zur Suche

Reporte zur Charge U026794

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

5Reporte angezeigt
0Todesfaelle
1Hospitalisiert
1Lebensbedrohlich
0Bleibende Schaeden
MI 2 NC 2 IL 1

VAERS 1944410

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U026794

schwer
Staat
MI
Alter
4,0
Geschlecht
M
Eingang
13.12.2021
Impfdatum
01.12.2021
Beginn
06.12.2021
Tage bis Beginn
5,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
CSF protein increased Diplopia Guillain-Barre syndrome Headache Lumbar puncture abnormal Magnetic resonance imaging spinal abnormal Muscular weakness Myalgia Vomiting

Symptomtext

Patient presented to ED 12/8/2021 with muscle aches and weakness, headaches, vomiting, and double vision. Over the next 2 days he had rapid progression of ascending paralysis and was diagnosed with Guillan Barre syndrome.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Guillain-Barre syndrome
Hospital-Tage
-
Labordaten
MRI spine showing enhancement of spinal roots and cauda equina. Lumbar puncture showing elevated protein in CSF.
Aktuelle Erkrankungen
Upper respiratory infection
Vorgeschichte
None. But patient did have episode of muscle weakness that required intensive physical therapy at age 2 of unknown etiology.
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2491993

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U026794

mild
Staat
IL
Alter
4,0
Geschlecht
F
Eingang
27.10.2022
Impfdatum
25.10.2022
Beginn
26.10.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Immunisation reaction Injection site erythema Injection site reaction Injection site urticaria Injection site warmth

Symptomtext

Mother called clinic on 10/27 for immunization reaction. Received vaccines on 10/25. Spoke to mother, states child looks like she had a reaction to vaccines on both of her legs that started on Wednesday morning.. Received proquad on right leg and kinrix on left leg. Right leg has little welts and redness, says its a circular shape about 4 inches. Some welts look fluid filled. No drainage, no bleeding. Left leg looks likes is red circle, about 3 in.. Feels warm to touch, not hard. No fevers, tmax 99.9. able to walk just fine, doesn't seem bothered by it. Has uri sx. No s/s of resp distress. Otherwise acting appropriately.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Currently sick with cough and congestion - viral uri
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2196611

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U026794

mild
Staat
NC
Alter
4,0
Geschlecht
M
Eingang
24.03.2022
Impfdatum
18.03.2022
Beginn
19.03.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema

Symptomtext

Patient received Proquad and Kinrix on 3/18/22. Mom reported large red area at injection site which improved with time. At visit on 3/23/22 mild redness at patients upper right anterior/lateral thigh. No further treatment needed

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
NONE
Vorgeschichte
ASTIGMATISM & PSEUDOSTRABISMUS
Andere Medikamente
MULTIVITAMIN DAILY AND EPI PEN PRN
Allergien
AMOXICILLIN, EGG, MILK PRODUCTS AND PENICILLIN
Vorherige Impfungen
-

VAERS 2386688

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U026794

gering
Staat
MI
Alter
-
Geschlecht
F
Eingang
23.07.2022
Impfdatum
12.07.2022
Beginn
12.07.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

No additional AE reported.; patient was administered MMRII [T033814 10/5/2022] and PROQUAD [U026794 2/26/2023], instead of MMRII and VARIVAX.; patient was administered MMRII [T033814 10/5/2022] and PROQUAD [U026794 2/26/2023], instead of MMRII and VARIVAX.; This spontaneous report was received from a medical assistant and refers to an 18-month-old female patient. Her medical history, concurrent conditions and concomitant therapies were not reported. On 12-JUL-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) subcutaneous injection, lot number U026794, expiration date: 26-FEB-2023 (dose, strength, and route of administration were not provided), and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) subcutaneous injection, lot number T033814, expiration date: 05-OCT-2022 (dose, strength, and route of administration were not provided) both administered for prophylaxis (overdose); instead of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II), and varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, administered for prophylaxis (dose, strength, lot number, expiration date, and route of administration were not provided) (wrong product administered). No additional adverse event was reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2386645

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U026794

gering
Staat
NC
Alter
4,0
Geschlecht
F
Eingang
23.07.2022
Impfdatum
26.05.2022
Beginn
26.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration No adverse event

Symptomtext

No additional adverse event; Caller is a Merck agent calling to report an adverse event on behalf of a vaccine coordinator for PROQUAD. The vaccine coordinator is not on the line. Caller reports that she received an email from the customer notifying her that a dose of PROQUAD was; This spontaneous report was received from an other health care professional via company representative concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history, and concomitant therapies were not reported. On an unspecified day, the patient was inadvertently vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) administered intramuscularly (Incorrect route of product administration) administered as prophylaxis and reconstituted with sterile diluent (dosage information, lot number, and expiration date were not provided). No additional adverse events (AE) were reported. Follow up information has been received from the clinical supervisor at the pediatric office on 21-JUN-2022. Patient's identifiers were provided, therefore, this case is now considered valid. The patient was a 4-year-old female, who on 26-MAY-2022, presented to the office with her grandmother, for her 4 years old child check up. The measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot number U026794, expiration date 26-FEB-2023, was ordered as appropriate for age. The Certified Medical Assistant who prepared the vaccine administered it intramuscularly(in the left vastus lateralis) instead of subcutaneously as recommended in the packaging insert. The patient was not harmed. No adverse reactions were noticed. No post vaccine concerns were presented. The CMA was supervised by a registered nurse, who addressed the error inmediately and education was provided, the incident was discussed and the parents were advised. The reporter considered the event was not related to measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-